Virbac Market Cap

Virbac has a market cap or net worth of $3.08 billion as of June 13, 2025. Its market cap has decreased by -5.98% in one year.

Market Cap

3.08B

Enterprise Value

3.26B

Revenue

1.45B

Ranking

n/a

PE Ratio

20.47

Stock Price

$346.00

Market Cap Chart

Since August 8, 1994, Virbac's market cap has increased from 263.48M to 3.08B, an increase of 1,068.34%. That is a compound annual growth rate of 8.29%.

Market Cap History

Date	Market Cap	% Change
Jun 13, 2025	3.08B	12.18%
Dec 31, 2024	2.74B	-18.21%
Dec 29, 2023	3.36B	62.92%
Dec 30, 2022	2.06B	-49.48%
Dec 31, 2021	4.08B	65.97%
Dec 31, 2020	2.46B	9.81%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.60B
Veradigm	747.25M
Elite Pharmaceuticals	726.32M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	637.25M
CytoDyn	442.16M
Glass House Brands	419.90M
Northwest Biotherapeutics	394.88M

Market Cap Rankings